Keytruda Market – Advancing Immunotherapy Across Cancer Care

added blog Health

2026-10-15 04:48:16 -

The Keytruda Market centers on pembrolizumab, an immunotherapy medicine that blocks the PD-1 pathway and helps the immune system recognize and attack cancer cells. Its use depends on the specific cancer type, disease stage, biomarker status, previous treatments, and applicable regulatory approvals. Keytruda is part of the broader development of immune checkpoint inhibitors in oncology....

0 Comments 0 Shares 15 Views 0 Reviews